Evidence map›Paper›PMID 30906919›Full record

ArticleBiotarget2018

From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy.

Ons Mamai, Eswari Dodagatta-Marri, Rosemary J Akhurst

Open access · hybridAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Biotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ons Mamai *UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Eswari Dodagatta-Marri *UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Rosemary J AkhurstUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
UCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Leigh Clarke · 1999 to 2026
$209.7M
Advancing the translatability of mouse models for cancer immunotherapyR01CA210561 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AKHURST, ROSEMARY J · 2018 to 2021
$2.0M
Circulating cells as tools to study vascular pathobiology of HHTR01HL122869 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AKHURST, ROSEMARY J · 2015 to 2018
$2.0M
NCI NIH HHS P30 CA082103NCI NIH HHS R01 CA210561NHLBI NIH HHS R01 HL122869
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30906919
PMCPMC6428074
OpenAlexW2905853868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.